(Q30459616)

14 September 2017

Update on corticotropin-releasing factor pharmacotherapy for psychiatric disorders: a revisionist view (English)

1 reference

14 September 2017

0 references

1

George F Koob

1 reference

14 September 2017

Eric P Zorrilla

2

1 reference

14 September 2017

language of work or name

English

0 references

publication date

1 January 2012

1 reference

14 September 2017

Neuropsychopharmacology

1 reference

14 September 2017

37

1 reference

14 September 2017

1

1 reference

14 September 2017

308-309

1 reference

Prevention of social stress-escalated cocaine self-administration by CRF-R1 antagonist in the rat VTA.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3238086

Multicenter, randomized, double-blind, active comparator and placebo-controlled trial of a corticotropin-releasing factor receptor-1 antagonist in generalized anxiety disorder

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3238086

Progress in corticotropin-releasing factor-1 antagonist development

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3238086

Neurobiological mechanisms of addiction: focus on corticotropin-releasing factor.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3238086

CRF and CRF receptors: role in stress responsivity and other behaviors

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3238086

A selective, non-peptide CRF receptor 1 antagonist prevents sodium lactate-induced acute panic-like responses.

20 June 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FNPP.2011.213

Preliminary evidence of anxiolytic effects of the CRF(1) receptor antagonist R317573 in the 7.5% CO(2) proof-of-concept experimental model of human anxiety.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3238086

26 November 2018

Identifiers

DOI

10.1038/NPP.2011.213

1 reference

Dimensions Publication ID

14 September 2017

0 references

1 reference

14 September 2017

PubMed publication ID

22157874

1 reference